Related Experiment Video

Updated: Jun 26, 2026

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

Senescence and cell death pathways and their role in cancer therapeutic outcome

M V Chiantore1, S Vannucchi, G Mangino

  • 1Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanita, University of Rome, Rome, Italy.

Current Medicinal Chemistry
|January 20, 2009
PubMed

Insights

Anticancer drugs can trigger tumor suppression by activating latent cell death (apoptosis) or growth arrest (senescence) programs. Understanding these mechanisms is key to developing new cancer therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Genetics

Background:

  • Anticancer drugs can induce tumor suppression through latent cellular defense mechanisms.
  • These mechanisms involve programmed cell death (apoptosis, autophagy) or permanent growth arrest (senescence).
  • These responses are critical for preventing uncontrolled cell proliferation and tumor development.

Purpose of the Study:

  • To review the fundamental knowledge of cellular mechanisms that limit excessive proliferation.
  • To discuss the prognostic value of apoptosis and senescence detection in cancer.
  • To explore how anticancer drugs induce senescence or cell death based on tumor cell genetics.

Main Methods:

  • Literature review of anticancer drug-induced tumor suppression.
  • Analysis of cellular self-elimination pathways (apoptosis, autophagy).
  • Examination of growth arrest mechanisms (senescence).

Main Results:

  • Anticancer drug action relies on activating innate tumor suppressive programs.
  • Apoptosis and senescence are key mechanisms for eliminating or halting aberrant cells.
  • Drug-induced responses vary based on tumor cell genetic profiles and pathway integrity.

Conclusions:

  • Enhancing apoptosis and senescence pathways holds therapeutic potential for cancer treatment.
  • The study of these cellular responses is essential for advancing anticancer strategies.
  • Tailoring drug-induced senescence or cell death based on tumor genetics is a promising avenue.

More Related Videos

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies08:57

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies

Published on: September 19, 2025

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...